{"nct_id":"NCT06111014","title":"Continuation Study for Latozinemab","status":"ENROLLING_BY_INVITATION","status_verified_date":"2025-07","start_date":"2023-12-08","start_date_type":"ACTUAL","primary_completion_date":"2027-07-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-11-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ALEC"]}